Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹681 Cr₹498 Cr₹532 Cr₹662 Cr₹392 Cr

What is the latest Consolidated Net Profit of EMCURE PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of EMCURE PHARMACEUTICALS is ₹681 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹681 Cr
Mar2024₹498 Cr
Mar2023₹532 Cr
Mar2022₹662 Cr
Mar2021₹392 Cr

How is Consolidated Net Profit of EMCURE PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹681 Cr
36.76
Mar2024 ₹498 Cr
-6.36
Mar2023 ₹532 Cr
-19.66
Mar2022 ₹662 Cr
68.87
Mar2021 ₹392 Cr -

Compare Consolidated Net Profit of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹27,112.8 Cr 1.8% 2.7% -2.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,929.0 Cr 0.7% -4.2% -8.7% Stock Analytics
DIVIS LABORATORIES ₹169,644.0 Cr 0% -1% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹131,481.0 Cr 2.4% 4.5% 14.5% Stock Analytics
CIPLA ₹122,050.0 Cr 1.1% 0.2% -1.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,784.0 Cr -1% -2% -9.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

1.8%

2.7%

-2.9%

SENSEX

0.9%

0.7%

9.6%


You may also like the below Video Courses